[Tobacco and inflammatory bowel disease]

Area of Science:

• Gastroenterology
• Immunology
• Epidemiology

Context:

• The link between tobacco use and inflammatory bowel diseases (IBD) is extensively documented.
• Epidemiological studies indicate a complex, dichotomous relationship between smoking and IBD subtypes.

Purpose:

• To elucidate the differential effects of smoking on ulcerative colitis (UC) and Crohn's disease (CD).
• To identify nicotine as the key component mediating these effects and its mechanisms of action.

Summary:

• Smoking demonstrates a protective effect in ulcerative colitis, delaying onset and improving clinical outcomes.
• Conversely, smoking and passive smoking elevate the risk and severity of Crohn's disease, including increased need for surgery and relapses.
• Nicotine's impact on colonic mucus, intestinal permeability, and cellular immunity underlies these observed effects.

Impact:

• Findings underscore the critical need for Crohn's disease patients to cease smoking.
• Suggests potential therapeutic applications of transdermal nicotine for managing ulcerative colitis.